Psyllium husk and Nail dystrophy - a phase IV clinical study of FDA data

Summary:

Nail dystrophy is reported only by a few people who take Psyllium Husk.

The phase IV clinical study analyzes which people take Psyllium husk and have Nail dystrophy. It is created by eHealthMe based on reports of 672 people who have side effects while taking Psyllium husk from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 17, 2022

672 people reported to have side effects when taking Psyllium husk.
Among them, 2 people (0.3%) have Nail dystrophy.


What is Psyllium husk?

Psyllium husk has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 738 Psyllium husk users for its effectiveness, alternative drugs and more.

What is Nail dystrophy?

Nail dystrophy (bed formation of nail) is found to be associated with 607 drugs and 236 conditions by eHealthMe.

Number of Psyllium husk and Nail dystrophy reports submitted per year:

Could Psyllium husk cause Nail dystrophy?

Gender of people who have Nail dystrophy when taking Psyllium husk *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Nail dystrophy when taking Psyllium husk *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Common drugs people take besides Psyllium husk *:

  1. Hytrin: 2 people, 100.00%
  2. Lantus: 2 people, 100.00%
  3. Ambien: 2 people, 100.00%
  4. Aredia: 2 people, 100.00%
  5. Aspirin: 2 people, 100.00%
  6. Ativan: 2 people, 100.00%
  7. Avandia: 2 people, 100.00%
  8. Cordarone: 2 people, 100.00%
  9. Coumadin: 2 people, 100.00%
  10. Effexor: 2 people, 100.00%

Common side effects people have besides Nail dystrophy *:

  1. Weakness: 2 people, 100.00%
  2. General Physical Health Deterioration (weak health status): 2 people, 100.00%
  3. Enlarged Prostate: 2 people, 100.00%
  4. Enterobacter Pneumonia (lung inflammation caused by bacteria of the family enterobacteriaceae): 2 people, 100.00%
  5. Eye Irritation: 2 people, 100.00%
  6. Fainting (loss of consciousness and postural tone): 2 people, 100.00%
  7. Fall: 2 people, 100.00%
  8. Fever: 2 people, 100.00%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 100.00%
  10. Gait Disturbance: 2 people, 100.00%

Common conditions people have *:

  1. Osteoporosis (bones weak and more likely to break): 2 people, 100.00%
  2. Bone Loss: 2 people, 100.00%
  3. Aplastic Anemia: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Psyllium husk and have Nail dystrophy?

Check whether Nail dystrophy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Psyllium husk:

Nail dystrophy treatments and more:

COVID vaccines that are related to Nail dystrophy:

How severe was Nail dystrophy and when was it recovered:

Expand to all the drugs that have ingredients of blond psyllium:

All the drugs that are associated with Nail dystrophy:

All the conditions that are associated with Nail dystrophy:

How the study uses the data?

The study uses data from the FDA. It is based on blond psyllium (the active ingredients of Psyllium husk) and Psyllium husk (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: